HOME >> BIOLOGY >> NEWS
Common airborne substance makes asthmatics more sensitive to house dust mites: study

CHAPEL HILL -- Exposure to endotoxin, a bacterial substance found commonly in outdoor and indoor air, makes mite-allergic asthmatics more sensitive to house dust and may place them at increased risk of asthma attack.

The new research findings from the University of North Carolina at Chapel Hill School of Medicine are consistent with previous UNC studies showing exposure to ozone to make asthmatics more sensitive to allergens, the environmental triggers of allergic reactions. Both ozone and endotoxin are not allergens; however, they can cause portions of the respiratory tract to become inflamed.

The study is published this week in the online December issue of the Journal of Allergy and Clinical Immunology.

Endotoxin is a complex of lipids (fats) and sugar molecules that's released through the outer cell wall of common bacteria. When the bacteria die, the cell wall collapses and endotoxin is released into the environment, finding its way into the air and dust.

"We know that asthmatics can have asthma attacks triggered by various environmental exposures, but we don't always know why certain circumstances precipitate asthma attacks when there are no clear-cut exposures to the allergens they are sensitized to," said Dr. Brian A. Boehlecke, lead author of the report, professor of medicine in UNC's pulmonary medicine division and member of UNC's Center for Environmental Medicine, Asthma and Lung Biology.

"Now it appears that various airborne irritants such as ozone and endotoxin, which can cause airway inflammation, may interact synergistically with other causes of airway problems, including allergens, to make asthma worse," he said.

The new study involved 14 participants with mild asthma for whom skin testing showed allergies to house dust mites, one of the most common airborne allergens. Study participants inhaled relatively low levels of endotoxin over four hours that approximated those levels found in some homes and off
'"/>

Contact: Leslie Lang
llang@med.unc.edu
919-843-9687
University of North Carolina School of Medicine
9-Dec-2003


Page: 1 2

Related biology news :

1. Common cold virus can cause polio in mice when injected into muscles
2. Common call for action on European Research Council (ERC)
3. Common therapy for HIV associated with cervical abnormality regression
4. Common chemicals morphing into potential toxins in Arctic
5. Common worm provides insights into salmonella virulence
6. Common virus may contribute to uncommon bone disease in children
7. Common genetic damages in non-dividing cells lead to the creation of mutant proteins
8. Common nutrients fed to pregnant mice altered their offsprings coat color
9. Common treatment for depression is safe and effective for Alzheimers patients
10. Common gene variant increases risk of atherosclerosis
11. Common thyroid cancer gene mutation found

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... 05, 2020 , ... Regenative Labs has received approval from the Centers for ... them the first Wharton’s jelly allografts to be assigned a Q code and be ... the first Wharton’s jelly allograft product to be recognized as a 361 HCT/P by ...
(Date:7/18/2020)... ... July 16, 2020 , ... ... effectiveness of the Invictus Medical Neoasis™ active noise control device to attenuate typical ... that the Neoasis™ device attenuated the alarm sounds from patient monitors, ventilators and ...
(Date:7/2/2020)... ... 01, 2020 , ... AltruBio Inc. http://www.altrubio.com , a ... for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European Hematology Association ... of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase 1 single ...
Breaking Biology News(10 mins):
(Date:8/3/2020)... ... August 03, 2020 , ... Introducing Ardent Animal Health – ... , Known as MediVet Biologics since its formation in 2016, ... The new Ardent Animal Health will build on its base of innovative therapies for ...
(Date:7/31/2020)... ... July 29, 2020 , ... Editas Medicine, ... provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell ... into a strategic partnership whereby Catalent will provide support for the development, manufacturing, ...
(Date:7/18/2020)... ... July 16, 2020 , ... After research model surgery and ... a great surgery is only the beginning of a successful study, while protecting and ... Join Brad Gien, Global Head of Surgery from Envigo in a ...
(Date:7/10/2020)... (PRWEB) , ... July 09, ... ... biotechnology company, announced today that Massachusetts Institute of Technology (MIT) has expanded ... broader license allows PathSensors to move into the point-of-care diagnostic market, focusing ...
Breaking Biology Technology:
Cached News: